TRIM16 inhibitors refer to a chemical class targeting the TRIM16 protein, which belongs to the tripartite motif (TRIM) family of proteins. TRIM16, like other TRIM family members, is characterized by the presence of a RING finger domain, one or two B-box domains, and a coiled-coil region. These structural features are associated with various biological roles, particularly those involved in ubiquitination processes, which are crucial for protein degradation and regulation of protein activity. Ubiquitination, a post-translational modification where ubiquitin proteins are attached to substrate proteins, plays a central role in cellular homeostasis, signal transduction, and the maintenance of protein quality control. The regulation of TRIM16's activity by inhibitors can therefore influence pathways related to protein degradation, cell cycle control, and potentially cellular response to external stressors or internal damage.
Chemically, TRIM16 inhibitors are designed to interfere with the functional domains of the TRIM16 protein, particularly targeting the RING finger and B-box domains involved in its ubiquitin ligase activity. This inhibition can alter the ability of TRIM16 to interact with other proteins or substrates in the ubiquitin-proteasome system. The molecular structures of these inhibitors typically possess features that allow them to bind selectively to TRIM16, blocking its interaction with target proteins or preventing its structural activation. Furthermore, research into TRIM16 inhibitors often focuses on understanding the specific binding interactions between the inhibitor molecules and the TRIM16 domains, allowing for improved selectivity and potency in modulating the protein's activity. By exploring the detailed structure-activity relationships (SAR) of these inhibitors, researchers can optimize their chemical frameworks for enhanced specificity in affecting TRIM16-dependent biological pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
TRIM16 is implicated in autophagy, and Withaferin A inhibits autophagy by disrupting the formation of autophagosomes, thus inhibiting TRIM16. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
TRIM16 is involved in autophagic processes; Chloroquine inhibits autophagy by preventing lysosome acidification, thereby inhibiting TRIM16. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
As an autophagy inhibitor, 3-Methyladenine prevents autophagosome formation, which is a process associated with TRIM16 activity. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $165.00 | ||
Spautin-1 promotes the degradation of autophagy-related proteins, indirectly inhibiting TRIM16 by impairing autophagic flux. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, a kinase involved in the autophagy pathway, therefore, its inhibition can downregulate TRIM16 function in autophagy. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor, which impairs autophagy; TRIM16, which is associated with this pathway, is functionally inhibited as a result. | ||||||
SAR405 | 1523406-39-4 | sc-507416 | 1 mg | $125.00 | ||
SAR405 inhibits VPS34, a kinase involved in autophagy, leading to the functional inhibition of TRIM16 which participates in this pathway. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
TRIM16 function is associated with the autophagic pathway; Bafilomycin A1 inhibits the fusion of autophagosomes and lysosomes, inhibiting TRIM16. | ||||||
SBI-0206965 | 1884220-36-3 | sc-507431 | 10 mg | $122.00 | ||
SBI-0206965 inhibits ULK1, key in autophagy initiation, thus functionally inhibiting TRIM16 by preventing autophagosome formation. | ||||||
MHY1485 | 326914-06-1 | sc-507522 | 10 mg | $140.00 | ||
MHY1485 is an mTOR activator and by enhancing mTOR activity, it inhibits autophagy, thereby functionally inhibiting TRIM16. | ||||||